The correlation between Cytokines imbalance and Vitamin D level in Patients with early Chronic Obstructive Pulmonary Disease (COPD) and the role of Vitamin D in Pulmonary Disease
DOI:
https://doi.org/10.1996/pjcm.v29i2.838Keywords:
Th1/Th2, COPD, Vitamin D, CytokinesAbstract
Background: Vitamin D, recognized for its dual role as an immune regulator and essential nutrient crucial for human well-being, exerts a multifaceted impact on the intricate immune processes found in individuals suffering from Chronic Obstructive Pulmonary Disease (COPD). In addition to its established functions in maintaining phosphate-calcium balance and bone mineralization, it exerts both direct and indirect effects on cellular elements within the COPD environment, thereby influencing the levels of inflammatory factors in the airways. Recent research has unveiled a compelling link between VDD and COPD, demonstrating a positive association between pulmonary function and vitamin D levels in COPD patients. Objective: The study sought to ascertain the role of sunlight and vitamin D in lung disease, as well as the relationship between vitamin D levels and cytokine discord in patients with early-stage chronic obstructive pulmonary disease (COPD). Methodology: A prospective study was conducted at Ponch Medical College, Rawalakot, between January 2020 to December 2020 and comprised 120 patients. COPD pulmonary function (LF) I & COPD LF II patients were divided into two groups (n = 60 each). An immunosorbent assay that uses enzymes was used to measure the blood levels of inflammatory TNF-α, IFN-γ, interleukin 4 (IL-4), and IL-6 in order to identify the Th1/Th2 marker. A proportion of IFN-γ to IL-4 was also a part of the treatment. The quantity of 25 [OH]D, or 25-hydroxyl vitamin D, in the blood was determined by chemiluminescent assay. The correlations between alterations in the aforementioned variables and the LF or vitamin D level were assessed after statistical processing. Results: Between the LF I alongside LF II groups, there was a significant difference (p < 0.04) in FEV1pred%, FEV1 or IFN-γ, IL-4, F, IFN-γ/IL-4, and IL-6. In patients with early-stage COPD, cytokines (Th1/Th2) were significantly correlated with forced volume percent (FEV1pred%) (r < 0.485, p < 0.002) and compelled exhalation volume/forced lifespan (FEV1/FVC) (r = 0.254, p = 0.015). Additionally, a significant correlation was observed between Th1/Th2 inflammatory mediators and the presence of 25 (level and FEV1pred% (r = 0.571, p < 0.001), whereas vitamin D level was associated with (r = 0.21, p < 0.002). Conclusion: Most cases with early-stage COPD had a vitamin D deficiency. Together with the FEV1/FVC LF parameters, it showed a positive correlation. This research offers experimental evidence in favour of vitamin D's role in COPD prevention and treatment, as well as possible anti-inflammatory action mechanisms.References
Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990 2017: A systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8:585 96.
Huang X, Zhu Z, Guo X, Kong X. The roles of microRNAs in the pathogenesis of chronic obstructive pulmonary disease. Int Immunopharmacol. 2019;67:335 47.
RaoW, Wang S, Duleba M, Niroula S, Goller K, Xie J, et al. Regenerative metaplastic clones in COPD lung drive inflammation and fibrosis. Cell. 2020;181:848 64.e18.
Khan DM, Ullah A, Randhawa FA, Iqtadar S, Butt NF, Waheed K. Role of vitamin D in reducing number of acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients. Pak J Med Sci. 2017;33:610 4.
Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D’Souza GA, Gupta D, et al. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci. 2006;48:23 9.
Cai X, Zhao Y, Deng X, Fang F. Effect of a two way quality feedback nursing model on patients with chronic obstructive pulmonary disease. Ann Palliat Med. 2020;9:3182 6.
Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison’s Principles of Internal Medicine. 19th ed. New York USA: Mcgraw Hill; 2015.
Burkes RM, Ceppe AS, Doerschuk CM, Couper D, Hoffman EA. Comellas AP, et al. (2020). Associations between 25-hydroxy-vitamin D levels, lung function, and exacerbation outcomes in COPD: An analysis of the SPIROMICS cohort. Chest. 157;856-65.
Chen J, Li X, Huang C, Lin Y, Dai Q. Change of serum inflammatory cytokines levels in patients with chronic obstructive pulmonary disease, pneumonia and lung cancer. Technol Cancer Res Treat. 2020;19:1533033820951807.
Group of Chronic Obstructive Pulmonary Disease, Branch of Respiratory Diseases, Chinese Medical Association. Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2021). Chin J Tuberc Respir Dis. 2021;44(3): 170–205.
Czaja AJ, Montano-Loza MJ. Evolving role of vitamin D in immune-mediated disease and its implications in autoimmune hepatitis. Dig Dis Sci. 2019;64: 324–44.
Fei J, Fu L, Cao W, Hu B, Zhao H, Li JB. Low vitamin D status is associated with epithelial-mesenchymal transition in patients with chronic obstructive pulmonary disease. J Immunol. 2019;203: 1428-35.
Singh S, Verma SK, Kumar S, Ahmad MK, Nischal A, Singh SK, et al. (2018). Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers. Immunol Lett. 2018;196: 1-10.
Silva BSA, Lira FS, Ramos D, Uzeloto JS, Rossi FE, Freire AP, et al. Severity of COPD and its relationship with IL-10. Cytokine. 2018;106: 95–100.
Fu L, Fei J, Tan ZX, Chen YH, Hu B, Xiang HX, et al. Low vitamin D status is associated with inflammation in patients with chronic obstructive pulmonary disease. J Immunol. 2021;206(3):515-23.
Burkes RM, Ceppe AS, Doerschuk CM, Couper D, Hoffman EA, Comellas AP, et al. Associations among 25 hydroxyvitamin D levels, lung function, and exacerbation outcomes in COPD: An analysis of the SPIROMICS cohort. Chest. 2020;157:856 65.
Dinlen N, Zenciroglu A, Beken S, Dursun A, Dilli D, Okumus N. Association of vitamin D deficiency with acute lower respiratory tract infections in newborns. J Matern Fetal Neonatal Med. 2016;29:928 32.
Zhu M, Wang T, Wang C, Ji Y. The association between vitamin D and COPD risk, severity, and exacerbation: An updated systematic review and meta analysis. Int J Chron Obstruct Pulmo Dis. 2016;11:2597 607
Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009;19: 468-483.
Baneen U, Naseem S. Correlation of severity of chronic obstructive pulmonary disease with serum vitamin D level. J Family Med Prim Care. 2019;8:2268 77.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Chest Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


